nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.155	0.248	CbGbCtD
Rifaximin—CYP3A4—Triamcinolone—psoriatic arthritis	0.117	0.188	CbGbCtD
Rifaximin—CYP3A4—Betamethasone—psoriatic arthritis	0.101	0.161	CbGbCtD
Rifaximin—CYP3A4—Prednisolone—psoriatic arthritis	0.0994	0.159	CbGbCtD
Rifaximin—CYP3A4—Prednisone—psoriatic arthritis	0.0939	0.15	CbGbCtD
Rifaximin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0586	0.0938	CbGbCtD
Rifaximin—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000937	0.0025	CcSEcCtD
Rifaximin—Haemorrhage—Prednisone—psoriatic arthritis	0.000936	0.0025	CcSEcCtD
Rifaximin—Malaise—Triamcinolone—psoriatic arthritis	0.00093	0.00248	CcSEcCtD
Rifaximin—Malaise—Methylprednisolone—psoriatic arthritis	0.000928	0.00248	CcSEcCtD
Rifaximin—Vertigo—Triamcinolone—psoriatic arthritis	0.000927	0.00247	CcSEcCtD
Rifaximin—Syncope—Triamcinolone—psoriatic arthritis	0.000925	0.00247	CcSEcCtD
Rifaximin—Vertigo—Methylprednisolone—psoriatic arthritis	0.000925	0.00247	CcSEcCtD
Rifaximin—Syncope—Methylprednisolone—psoriatic arthritis	0.000923	0.00246	CcSEcCtD
Rifaximin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000915	0.00244	CcSEcCtD
Rifaximin—Neutropenia—Methotrexate—psoriatic arthritis	0.000914	0.00244	CcSEcCtD
Rifaximin—Dysuria—Methotrexate—psoriatic arthritis	0.000914	0.00244	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000908	0.00242	CcSEcCtD
Rifaximin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000906	0.00242	CcSEcCtD
Rifaximin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000904	0.00241	CcSEcCtD
Rifaximin—Shock—Prednisolone—psoriatic arthritis	0.000901	0.0024	CcSEcCtD
Rifaximin—Cough—Triamcinolone—psoriatic arthritis	0.0009	0.0024	CcSEcCtD
Rifaximin—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000892	0.00238	CcSEcCtD
Rifaximin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000885	0.00236	CcSEcCtD
Rifaximin—Myalgia—Triamcinolone—psoriatic arthritis	0.000878	0.00234	CcSEcCtD
Rifaximin—Pneumonia—Methotrexate—psoriatic arthritis	0.000877	0.00234	CcSEcCtD
Rifaximin—Myalgia—Methylprednisolone—psoriatic arthritis	0.000876	0.00234	CcSEcCtD
Rifaximin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000876	0.00234	CcSEcCtD
Rifaximin—Infestation NOS—Methotrexate—psoriatic arthritis	0.000872	0.00232	CcSEcCtD
Rifaximin—Infestation—Methotrexate—psoriatic arthritis	0.000872	0.00232	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00087	0.00232	CcSEcCtD
Rifaximin—Depression—Methotrexate—psoriatic arthritis	0.000869	0.00232	CcSEcCtD
Rifaximin—Flushing—Prednisone—psoriatic arthritis	0.000869	0.00232	CcSEcCtD
Rifaximin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000868	0.00232	CcSEcCtD
Rifaximin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000868	0.00232	CcSEcCtD
Rifaximin—Discomfort—Triamcinolone—psoriatic arthritis	0.000868	0.00231	CcSEcCtD
Rifaximin—Discomfort—Methylprednisolone—psoriatic arthritis	0.000866	0.00231	CcSEcCtD
Rifaximin—Dry mouth—Triamcinolone—psoriatic arthritis	0.000859	0.00229	CcSEcCtD
Rifaximin—Angioedema—Betamethasone—psoriatic arthritis	0.000855	0.00228	CcSEcCtD
Rifaximin—Angioedema—Dexamethasone—psoriatic arthritis	0.000855	0.00228	CcSEcCtD
Rifaximin—Angiopathy—Prednisone—psoriatic arthritis	0.000849	0.00227	CcSEcCtD
Rifaximin—Confusional state—Methylprednisolone—psoriatic arthritis	0.000847	0.00226	CcSEcCtD
Rifaximin—Malaise—Dexamethasone—psoriatic arthritis	0.000844	0.00225	CcSEcCtD
Rifaximin—Malaise—Betamethasone—psoriatic arthritis	0.000844	0.00225	CcSEcCtD
Rifaximin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000842	0.00224	CcSEcCtD
Rifaximin—Vertigo—Betamethasone—psoriatic arthritis	0.000841	0.00224	CcSEcCtD
Rifaximin—Vertigo—Dexamethasone—psoriatic arthritis	0.000841	0.00224	CcSEcCtD
Rifaximin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00084	0.00224	CcSEcCtD
Rifaximin—Syncope—Betamethasone—psoriatic arthritis	0.000839	0.00224	CcSEcCtD
Rifaximin—Syncope—Dexamethasone—psoriatic arthritis	0.000839	0.00224	CcSEcCtD
Rifaximin—Infection—Triamcinolone—psoriatic arthritis	0.000836	0.00223	CcSEcCtD
Rifaximin—Infection—Methylprednisolone—psoriatic arthritis	0.000834	0.00223	CcSEcCtD
Rifaximin—Haematuria—Methotrexate—psoriatic arthritis	0.000831	0.00222	CcSEcCtD
Rifaximin—Shock—Triamcinolone—psoriatic arthritis	0.000828	0.00221	CcSEcCtD
Rifaximin—Insomnia—Prednisolone—psoriatic arthritis	0.000828	0.00221	CcSEcCtD
Rifaximin—Shock—Methylprednisolone—psoriatic arthritis	0.000826	0.0022	CcSEcCtD
Rifaximin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000824	0.0022	CcSEcCtD
Rifaximin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000822	0.00219	CcSEcCtD
Rifaximin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000822	0.00219	CcSEcCtD
Rifaximin—Epistaxis—Methotrexate—psoriatic arthritis	0.000822	0.00219	CcSEcCtD
Rifaximin—Mental disorder—Prednisone—psoriatic arthritis	0.00082	0.00219	CcSEcCtD
Rifaximin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000816	0.00218	CcSEcCtD
Rifaximin—Malnutrition—Prednisone—psoriatic arthritis	0.000815	0.00217	CcSEcCtD
Rifaximin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000814	0.00217	CcSEcCtD
Rifaximin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000812	0.00217	CcSEcCtD
Rifaximin—Myalgia—Dexamethasone—psoriatic arthritis	0.000797	0.00212	CcSEcCtD
Rifaximin—Myalgia—Betamethasone—psoriatic arthritis	0.000797	0.00212	CcSEcCtD
Rifaximin—Discomfort—Dexamethasone—psoriatic arthritis	0.000787	0.0021	CcSEcCtD
Rifaximin—Discomfort—Betamethasone—psoriatic arthritis	0.000787	0.0021	CcSEcCtD
Rifaximin—Haemoglobin—Methotrexate—psoriatic arthritis	0.000786	0.0021	CcSEcCtD
Rifaximin—Hypotension—Methylprednisolone—psoriatic arthritis	0.000785	0.00209	CcSEcCtD
Rifaximin—Pain—Prednisolone—psoriatic arthritis	0.000783	0.00209	CcSEcCtD
Rifaximin—Haemorrhage—Methotrexate—psoriatic arthritis	0.000782	0.00209	CcSEcCtD
Rifaximin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000777	0.00207	CcSEcCtD
Rifaximin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000773	0.00206	CcSEcCtD
Rifaximin—Urethral disorder—Methotrexate—psoriatic arthritis	0.000767	0.00205	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000767	0.00205	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000765	0.00204	CcSEcCtD
Rifaximin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000764	0.00204	CcSEcCtD
Rifaximin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000764	0.00204	CcSEcCtD
Rifaximin—Insomnia—Triamcinolone—psoriatic arthritis	0.000761	0.00203	CcSEcCtD
Rifaximin—Insomnia—Methylprednisolone—psoriatic arthritis	0.00076	0.00203	CcSEcCtD
Rifaximin—Infection—Dexamethasone—psoriatic arthritis	0.000759	0.00202	CcSEcCtD
Rifaximin—Infection—Betamethasone—psoriatic arthritis	0.000759	0.00202	CcSEcCtD
Rifaximin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000756	0.00202	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000754	0.00201	CcSEcCtD
Rifaximin—Anaemia—Prednisone—psoriatic arthritis	0.000753	0.00201	CcSEcCtD
Rifaximin—Shock—Dexamethasone—psoriatic arthritis	0.000751	0.002	CcSEcCtD
Rifaximin—Shock—Betamethasone—psoriatic arthritis	0.000751	0.002	CcSEcCtD
Rifaximin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00075	0.002	CcSEcCtD
Rifaximin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000749	0.002	CcSEcCtD
Rifaximin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000749	0.002	CcSEcCtD
Rifaximin—Angioedema—Prednisone—psoriatic arthritis	0.000745	0.00199	CcSEcCtD
Rifaximin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000738	0.00197	CcSEcCtD
Rifaximin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000738	0.00197	CcSEcCtD
Rifaximin—Malaise—Prednisone—psoriatic arthritis	0.000735	0.00196	CcSEcCtD
Rifaximin—Vertigo—Prednisone—psoriatic arthritis	0.000732	0.00195	CcSEcCtD
Rifaximin—Syncope—Prednisone—psoriatic arthritis	0.000731	0.00195	CcSEcCtD
Rifaximin—Tinnitus—Methotrexate—psoriatic arthritis	0.000729	0.00195	CcSEcCtD
Rifaximin—Anorexia—Betamethasone—psoriatic arthritis	0.000728	0.00194	CcSEcCtD
Rifaximin—Anorexia—Dexamethasone—psoriatic arthritis	0.000728	0.00194	CcSEcCtD
Rifaximin—Urticaria—Prednisolone—psoriatic arthritis	0.000727	0.00194	CcSEcCtD
Rifaximin—Fatigue—Triamcinolone—psoriatic arthritis	0.000726	0.00194	CcSEcCtD
Rifaximin—Fatigue—Methylprednisolone—psoriatic arthritis	0.000724	0.00193	CcSEcCtD
Rifaximin—Pain—Triamcinolone—psoriatic arthritis	0.00072	0.00192	CcSEcCtD
Rifaximin—Loss of consciousness—Prednisone—psoriatic arthritis	0.000716	0.00191	CcSEcCtD
Rifaximin—Hypotension—Betamethasone—psoriatic arthritis	0.000714	0.0019	CcSEcCtD
Rifaximin—Hypotension—Dexamethasone—psoriatic arthritis	0.000714	0.0019	CcSEcCtD
Rifaximin—Angiopathy—Methotrexate—psoriatic arthritis	0.00071	0.00189	CcSEcCtD
Rifaximin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000705	0.00188	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000696	0.00186	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000696	0.00186	CcSEcCtD
Rifaximin—Arthralgia—Prednisone—psoriatic arthritis	0.000694	0.00185	CcSEcCtD
Rifaximin—Myalgia—Prednisone—psoriatic arthritis	0.000694	0.00185	CcSEcCtD
Rifaximin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000694	0.00185	CcSEcCtD
Rifaximin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000692	0.00185	CcSEcCtD
Rifaximin—Insomnia—Dexamethasone—psoriatic arthritis	0.000691	0.00184	CcSEcCtD
Rifaximin—Insomnia—Betamethasone—psoriatic arthritis	0.000691	0.00184	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000689	0.00184	CcSEcCtD
Rifaximin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000687	0.00183	CcSEcCtD
Rifaximin—Discomfort—Prednisone—psoriatic arthritis	0.000686	0.00183	CcSEcCtD
Rifaximin—Mental disorder—Methotrexate—psoriatic arthritis	0.000685	0.00183	CcSEcCtD
Rifaximin—Malnutrition—Methotrexate—psoriatic arthritis	0.000681	0.00182	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000674	0.0018	CcSEcCtD
Rifaximin—Urticaria—Triamcinolone—psoriatic arthritis	0.000669	0.00178	CcSEcCtD
Rifaximin—Urticaria—Methylprednisolone—psoriatic arthritis	0.000667	0.00178	CcSEcCtD
Rifaximin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000665	0.00177	CcSEcCtD
Rifaximin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000665	0.00177	CcSEcCtD
Rifaximin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000664	0.00177	CcSEcCtD
Rifaximin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000664	0.00177	CcSEcCtD
Rifaximin—Decreased appetite—Betamethasone—psoriatic arthritis	0.000664	0.00177	CcSEcCtD
Rifaximin—Infection—Prednisone—psoriatic arthritis	0.000661	0.00176	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000659	0.00176	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000659	0.00176	CcSEcCtD
Rifaximin—Back pain—Methotrexate—psoriatic arthritis	0.000659	0.00176	CcSEcCtD
Rifaximin—Fatigue—Dexamethasone—psoriatic arthritis	0.000658	0.00176	CcSEcCtD
Rifaximin—Fatigue—Betamethasone—psoriatic arthritis	0.000658	0.00176	CcSEcCtD
Rifaximin—Shock—Prednisone—psoriatic arthritis	0.000654	0.00175	CcSEcCtD
Rifaximin—Pain—Dexamethasone—psoriatic arthritis	0.000653	0.00174	CcSEcCtD
Rifaximin—Pain—Betamethasone—psoriatic arthritis	0.000653	0.00174	CcSEcCtD
Rifaximin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000652	0.00174	CcSEcCtD
Rifaximin—Skin disorder—Prednisone—psoriatic arthritis	0.000646	0.00172	CcSEcCtD
Rifaximin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000643	0.00171	CcSEcCtD
Rifaximin—Anorexia—Prednisone—psoriatic arthritis	0.000634	0.00169	CcSEcCtD
Rifaximin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000632	0.00169	CcSEcCtD
Rifaximin—Anaemia—Methotrexate—psoriatic arthritis	0.00063	0.00168	CcSEcCtD
Rifaximin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000629	0.00168	CcSEcCtD
Rifaximin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000629	0.00168	CcSEcCtD
Rifaximin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000625	0.00167	CcSEcCtD
Rifaximin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000625	0.00167	CcSEcCtD
Rifaximin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00062	0.00165	CcSEcCtD
Rifaximin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000619	0.00165	CcSEcCtD
Rifaximin—Malaise—Methotrexate—psoriatic arthritis	0.000614	0.00164	CcSEcCtD
Rifaximin—Vertigo—Methotrexate—psoriatic arthritis	0.000612	0.00163	CcSEcCtD
Rifaximin—Urticaria—Betamethasone—psoriatic arthritis	0.000607	0.00162	CcSEcCtD
Rifaximin—Urticaria—Dexamethasone—psoriatic arthritis	0.000607	0.00162	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000606	0.00162	CcSEcCtD
Rifaximin—Dizziness—Prednisolone—psoriatic arthritis	0.000605	0.00161	CcSEcCtD
Rifaximin—Asthenia—Triamcinolone—psoriatic arthritis	0.000604	0.00161	CcSEcCtD
Rifaximin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000604	0.00161	CcSEcCtD
Rifaximin—Body temperature increased—Betamethasone—psoriatic arthritis	0.000604	0.00161	CcSEcCtD
Rifaximin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000604	0.00161	CcSEcCtD
Rifaximin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000604	0.00161	CcSEcCtD
Rifaximin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000603	0.00161	CcSEcCtD
Rifaximin—Insomnia—Prednisone—psoriatic arthritis	0.000602	0.0016	CcSEcCtD
Rifaximin—Pruritus—Triamcinolone—psoriatic arthritis	0.000596	0.00159	CcSEcCtD
Rifaximin—Cough—Methotrexate—psoriatic arthritis	0.000594	0.00159	CcSEcCtD
Rifaximin—Pruritus—Methylprednisolone—psoriatic arthritis	0.000594	0.00158	CcSEcCtD
Rifaximin—Myalgia—Methotrexate—psoriatic arthritis	0.00058	0.00155	CcSEcCtD
Rifaximin—Arthralgia—Methotrexate—psoriatic arthritis	0.00058	0.00155	CcSEcCtD
Rifaximin—Chest pain—Methotrexate—psoriatic arthritis	0.00058	0.00155	CcSEcCtD
Rifaximin—Decreased appetite—Prednisone—psoriatic arthritis	0.000578	0.00154	CcSEcCtD
Rifaximin—Rash—Prednisolone—psoriatic arthritis	0.000577	0.00154	CcSEcCtD
Rifaximin—Dermatitis—Prednisolone—psoriatic arthritis	0.000577	0.00154	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000576	0.00154	CcSEcCtD
Rifaximin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000575	0.00153	CcSEcCtD
Rifaximin—Fatigue—Prednisone—psoriatic arthritis	0.000573	0.00153	CcSEcCtD
Rifaximin—Headache—Prednisolone—psoriatic arthritis	0.000573	0.00153	CcSEcCtD
Rifaximin—Discomfort—Methotrexate—psoriatic arthritis	0.000573	0.00153	CcSEcCtD
Rifaximin—Constipation—Prednisone—psoriatic arthritis	0.000569	0.00152	CcSEcCtD
Rifaximin—Confusional state—Methotrexate—psoriatic arthritis	0.00056	0.00149	CcSEcCtD
Rifaximin—Dizziness—Triamcinolone—psoriatic arthritis	0.000557	0.00148	CcSEcCtD
Rifaximin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000556	0.00148	CcSEcCtD
Rifaximin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000555	0.00148	CcSEcCtD
Rifaximin—Infection—Methotrexate—psoriatic arthritis	0.000552	0.00147	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisone—psoriatic arthritis	0.000548	0.00146	CcSEcCtD
Rifaximin—Asthenia—Betamethasone—psoriatic arthritis	0.000548	0.00146	CcSEcCtD
Rifaximin—Asthenia—Dexamethasone—psoriatic arthritis	0.000548	0.00146	CcSEcCtD
Rifaximin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000545	0.00145	CcSEcCtD
Rifaximin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000544	0.00145	CcSEcCtD
Rifaximin—Nausea—Prednisolone—psoriatic arthritis	0.000544	0.00145	CcSEcCtD
Rifaximin—Pruritus—Betamethasone—psoriatic arthritis	0.00054	0.00144	CcSEcCtD
Rifaximin—Pruritus—Dexamethasone—psoriatic arthritis	0.00054	0.00144	CcSEcCtD
Rifaximin—Skin disorder—Methotrexate—psoriatic arthritis	0.00054	0.00144	CcSEcCtD
Rifaximin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000537	0.00143	CcSEcCtD
Rifaximin—Vomiting—Triamcinolone—psoriatic arthritis	0.000535	0.00143	CcSEcCtD
Rifaximin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000534	0.00142	CcSEcCtD
Rifaximin—Rash—Triamcinolone—psoriatic arthritis	0.000531	0.00142	CcSEcCtD
Rifaximin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00053	0.00141	CcSEcCtD
Rifaximin—Anorexia—Methotrexate—psoriatic arthritis	0.00053	0.00141	CcSEcCtD
Rifaximin—Rash—Methylprednisolone—psoriatic arthritis	0.00053	0.00141	CcSEcCtD
Rifaximin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000529	0.00141	CcSEcCtD
Rifaximin—Urticaria—Prednisone—psoriatic arthritis	0.000528	0.00141	CcSEcCtD
Rifaximin—Headache—Triamcinolone—psoriatic arthritis	0.000527	0.00141	CcSEcCtD
Rifaximin—Headache—Methylprednisolone—psoriatic arthritis	0.000526	0.0014	CcSEcCtD
Rifaximin—Body temperature increased—Prednisone—psoriatic arthritis	0.000526	0.0014	CcSEcCtD
Rifaximin—Abdominal pain—Prednisone—psoriatic arthritis	0.000526	0.0014	CcSEcCtD
Rifaximin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000523	0.00139	CcSEcCtD
Rifaximin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000523	0.00139	CcSEcCtD
Rifaximin—Hypotension—Methotrexate—psoriatic arthritis	0.000519	0.00139	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000506	0.00135	CcSEcCtD
Rifaximin—Dizziness—Betamethasone—psoriatic arthritis	0.000505	0.00135	CcSEcCtD
Rifaximin—Dizziness—Dexamethasone—psoriatic arthritis	0.000505	0.00135	CcSEcCtD
Rifaximin—Insomnia—Methotrexate—psoriatic arthritis	0.000503	0.00134	CcSEcCtD
Rifaximin—Nausea—Triamcinolone—psoriatic arthritis	0.0005	0.00133	CcSEcCtD
Rifaximin—Nausea—Methylprednisolone—psoriatic arthritis	0.000499	0.00133	CcSEcCtD
Rifaximin—Dyspnoea—Methotrexate—psoriatic arthritis	0.000496	0.00132	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisone—psoriatic arthritis	0.00049	0.00131	CcSEcCtD
Rifaximin—Vomiting—Betamethasone—psoriatic arthritis	0.000486	0.0013	CcSEcCtD
Rifaximin—Vomiting—Dexamethasone—psoriatic arthritis	0.000486	0.0013	CcSEcCtD
Rifaximin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000483	0.00129	CcSEcCtD
Rifaximin—Rash—Dexamethasone—psoriatic arthritis	0.000482	0.00128	CcSEcCtD
Rifaximin—Rash—Betamethasone—psoriatic arthritis	0.000482	0.00128	CcSEcCtD
Rifaximin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000481	0.00128	CcSEcCtD
Rifaximin—Dermatitis—Betamethasone—psoriatic arthritis	0.000481	0.00128	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00048	0.00128	CcSEcCtD
Rifaximin—Fatigue—Methotrexate—psoriatic arthritis	0.000479	0.00128	CcSEcCtD
Rifaximin—Headache—Dexamethasone—psoriatic arthritis	0.000478	0.00128	CcSEcCtD
Rifaximin—Headache—Betamethasone—psoriatic arthritis	0.000478	0.00128	CcSEcCtD
Rifaximin—Asthenia—Prednisone—psoriatic arthritis	0.000477	0.00127	CcSEcCtD
Rifaximin—Pain—Methotrexate—psoriatic arthritis	0.000475	0.00127	CcSEcCtD
Rifaximin—Pruritus—Prednisone—psoriatic arthritis	0.000471	0.00126	CcSEcCtD
Rifaximin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000458	0.00122	CcSEcCtD
Rifaximin—Diarrhoea—Prednisone—psoriatic arthritis	0.000455	0.00121	CcSEcCtD
Rifaximin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000455	0.00121	CcSEcCtD
Rifaximin—Nausea—Betamethasone—psoriatic arthritis	0.000454	0.00121	CcSEcCtD
Rifaximin—Nausea—Dexamethasone—psoriatic arthritis	0.000454	0.00121	CcSEcCtD
Rifaximin—Urticaria—Methotrexate—psoriatic arthritis	0.000442	0.00118	CcSEcCtD
Rifaximin—Dizziness—Prednisone—psoriatic arthritis	0.00044	0.00117	CcSEcCtD
Rifaximin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000439	0.00117	CcSEcCtD
Rifaximin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000439	0.00117	CcSEcCtD
Rifaximin—Vomiting—Prednisone—psoriatic arthritis	0.000423	0.00113	CcSEcCtD
Rifaximin—Rash—Prednisone—psoriatic arthritis	0.000419	0.00112	CcSEcCtD
Rifaximin—Dermatitis—Prednisone—psoriatic arthritis	0.000419	0.00112	CcSEcCtD
Rifaximin—Headache—Prednisone—psoriatic arthritis	0.000417	0.00111	CcSEcCtD
Rifaximin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00041	0.00109	CcSEcCtD
Rifaximin—Asthenia—Methotrexate—psoriatic arthritis	0.000399	0.00106	CcSEcCtD
Rifaximin—Nausea—Prednisone—psoriatic arthritis	0.000395	0.00105	CcSEcCtD
Rifaximin—Pruritus—Methotrexate—psoriatic arthritis	0.000393	0.00105	CcSEcCtD
Rifaximin—Diarrhoea—Methotrexate—psoriatic arthritis	0.00038	0.00101	CcSEcCtD
Rifaximin—Dizziness—Methotrexate—psoriatic arthritis	0.000368	0.00098	CcSEcCtD
Rifaximin—Vomiting—Methotrexate—psoriatic arthritis	0.000353	0.000943	CcSEcCtD
Rifaximin—Rash—Methotrexate—psoriatic arthritis	0.00035	0.000935	CcSEcCtD
Rifaximin—Dermatitis—Methotrexate—psoriatic arthritis	0.00035	0.000934	CcSEcCtD
Rifaximin—Headache—Methotrexate—psoriatic arthritis	0.000348	0.000929	CcSEcCtD
Rifaximin—Nausea—Methotrexate—psoriatic arthritis	0.00033	0.000881	CcSEcCtD
